首页> 外文OA文献 >Feasibility study of a standardized novel animal model for cervical vertebral augmentation in sheep using a PTH derivate bioactive material
【2h】

Feasibility study of a standardized novel animal model for cervical vertebral augmentation in sheep using a PTH derivate bioactive material

机译:使用PTH衍生生物活性物质在绵羊中进行颈椎椎体标准化的新型动物模型的可行性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prophylactic local treatment involving percutaneous vertebral augmentation using bioactive materials is a new treatment strategy in spine surgery in humans for vertebral bodies at risk. Standardized animal models for this procedure are almost non-existent. The purpose of this study was to: (i) prove the efficacy of PTH derivate bioactive materials for new bone formation; and (ii) create a new, highly standardized cervical vertebral augmentation model in sheep. Three different concentrations of a modified form of parathyroid hormone (PTH) covalently bound to a fibrin matrix containing strontium carbonate were used. The same matrix without PTH and shams were used as controls. The bioactive materials were locally injected. Using a ventral surgical approach, a pre-set amount of material was injected under fluoroscopic guidance into the intertrabecular space of three vertebral bodies. Intravital fluorescent dyes were used to demonstrate new bone formation. After an observation period of four months, the animals were sacrificed, and vertebral bodies were processed for µCT, histomorphometry, histology and sequential fluorescence evaluation. Enhanced localized bone activity and new bone formation in the injected area could be determined for all experimental groups in comparison to the matrix alone and sham with the highest values detected for the group with a medium concentration of PTH.
机译:涉及使用生物活性材料经皮椎体增强的预防性局部治疗是人类脊柱外科手术中针对有风险的椎体的一种新治疗策略。此程序的标准化动物模型几乎不存在。这项研究的目的是:(i)证明PTH衍生生物活性材料对新骨形成的功效; (ii)在绵羊中创建新的高度标准化的颈椎椎体扩张模型。使用三种不同浓度的修饰形式的甲状旁腺激素(PTH),它们共价结合到含有碳酸锶的纤维蛋白基质上。不含PTH和异味的相同基质用作对照。将生物活性材料局部注射。使用腹腔外科手术方法,在荧光镜引导下将预定量的材料注射到三个椎体的小梁间隙中。玻璃体内荧光染料用于证明新的骨形成。在四个月的观察期后,处死动物,并处理椎体进行µCT,组织形态学,组织学和顺序荧光评估。与单独的基质和假药相比,对于所有实验组,可以确定所有实验组增强的局部骨活性和新的骨形成,对于中等浓度的PTH组,其检测值最高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号